According to United Therapeutics's latest financial reports the company's total assets are $7.16 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $7.16 B | 18.57% |
2022-12-31 | $6.04 B | 16.94% |
2021-12-31 | $5.16 B | 12.01% |
2020-12-31 | $4.61 B | 17.93% |
2019-12-31 | $3.91 B | 15.07% |
2018-12-31 | $3.40 B | 18.11% |
2017-12-31 | $2.87 B | 23.81% |
2016-12-31 | $2.32 B | 6.46% |
2015-12-31 | $2.18 B | 15.92% |
2014-12-31 | $1.88 B | -9.73% |
2013-12-31 | $2.08 B | 28.34% |
2012-12-31 | $1.62 B | 7.15% |
2011-12-31 | $1.51 B | 6.04% |
2010-12-31 | $1.43 B | 36.15% |
2009-12-31 | $1.05 B | 20.24% |
2008-12-31 | $0.87 B | 48.98% |
2007-12-31 | $0.58 B | 23.07% |
2006-12-31 | $0.47 B | 63.68% |
2005-12-31 | $0.29 B | 40.67% |
2004-12-31 | $0.20 B | 15.41% |
2003-12-31 | $0.17 B | -2.74% |
2002-12-31 | $0.18 B | -12.99% |
2001-12-31 | $0.21 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 3,060.33% | ๐บ๐ธ USA |
Eli Lilly LLY | $64.00 B | 793.07% | ๐บ๐ธ USA |
Baxter BAX | $28.27 B | 294.53% | ๐บ๐ธ USA |
Gilead Sciences GILD | $62.12 B | 766.82% | ๐บ๐ธ USA |
Cardinal Health CAH | $46.57 B | 549.83% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $75.11 B | 948.05% | ๐ฌ๐ง UK |
Cytokinetics
CYTK | $0.82 B | -88.50% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $43.47 B | 506.66% | ๐ฎ๐ฑ Israel |